Analyst Price Target is $6.50
▲ +97.57% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for SOPHiA GENETICS in the last 3 months. The average price target is $6.50, with a high forecast of $8.00 and a low forecast of $5.00. The average price target represents a 97.57% upside from the last price of $3.29.
Current Consensus is
Moderate Buy
The current consensus among 4 investment analysts is to moderate buy stock in SOPHiA GENETICS. This rating has held steady since August 2024, when it changed from a Buy consensus rating.
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.
Read More